Contract Research Organisations
Differentiate your DCT offer with cross-border DHT governance sponsors can trust.
Differentiate your DCT offering with a DHT compliance partner.
For CRO leaders building decentralised and DHT-enabled trial capabilities for sponsor clients — without hiring a specialist regulatory team from scratch.
Your sponsors are asking harder questions. Wearables. Point-of-care devices. SaMD in protocols. AI-driven endpoints. The CROs winning these RFPs have a credible DHT compliance story — the ones without one keep getting asked to partner with someone who does. Building the capability in-house takes 18–24 months and a team you can't easily justify. We become that capability, white-labelled into your offering or visible as a named specialist, whichever your sponsor prefers.
WHAT WE HANDLE
1. Sponsor RFP Support
DHT sections of proposals, compliance narratives, and regulatory defence for sponsor evaluation — written in the language sponsors' RA teams expect.
2. Study-Specific DHT Governance
Classification, validation, and deployment support for individual studies in your pipeline, mobilised on CRO timelines.
3. DCT Platform Integration
Compliance architecture for your own DCT platform or for third-party platforms you resource through — aligned with FDA, EMA, and ICH E6(R3).
4. Capability Build
If you want to eventually own the capability: training, SOPs, and a phased handover plan so your internal teams can take it in-house on a defined timeline.
HOW WE WORK WITH CROs
Engagement model — Named partner, white-label, or embedded — whichever suits the sponsor relationship.
Study execution — Fixed-scope DHT deliverables integrated with your existing project plan and PM cadence.
Growth — As your DHT pipeline grows, we scale with you or hand over progressively — your call.
WHY CROs CHOOSE QOINTA
Sponsor-fluent. We understand both sides of the CRO–sponsor relationship and protect yours.
Flexible engagement. Named partner, white-label, embedded — whatever the sponsor needs.
No competition for your core scope. We focus on DHT compliance, not on clinical operations, biostatistics, or monitoring.
Faster than hiring. Day-one capability without an 18-month team build.

